Published in Obstet Gynecol on November 01, 2009
Cardiovascular risk factors one year after a hypertensive disorder of pregnancy. J Womens Health (Larchmt) (2014) 1.40
The Human Placenta Project: placental structure, development, and function in real time. Placenta (2014) 1.10
Physicians' knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy (2011) 0.92
Postpartum healthcare after gestational diabetes and hypertension. J Womens Health (Larchmt) (2014) 0.82
The long-term psychiatric and medical prognosis of perinatal mental illness. Best Pract Res Clin Obstet Gynaecol (2013) 0.81
Are the metabolic changes of pregnancy reversible in the first year postpartum? Diabetologia (2015) 0.79
The Kaiser Permanente Northern California research program on genes, environment, and health (RPGEH) pregnancy cohort: study design, methodology and baseline characteristics. BMC Pregnancy Childbirth (2016) 0.75
Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol (2009) 2.56
Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol (2006) 5.99
Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop. Obstet Gynecol (2012) 4.63
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med (2003) 4.04
Effectiveness of electronic fetal monitoring with additional ST analysis in vertex singleton pregnancies at >36 weeks of gestation: an individual participant data metaanalysis. Am J Obstet Gynecol (2013) 3.10
A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis. N Engl J Med (2015) 2.86
Impact of maternal age on obstetric outcome. Obstet Gynecol (2005) 2.60
First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol (2005) 2.40
First- and second-trimester evaluation of risk for Down syndrome. Obstet Gynecol (2007) 2.31
Antiphospholipid antibodies in stillbirth. Obstet Gynecol (2013) 2.04
Unjustified increase in cost of care resulting from U.S. Food and Drug Administration approval of Makena (17α-hydroxyprogesterone caproate). Obstet Gynecol (2011) 2.01
The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol (2007) 1.65
Karyotype versus microarray testing for genetic abnormalities after stillbirth. N Engl J Med (2012) 1.56
Hospital readmission after delivery: evidence for an increased incidence of nonurogenital infection in the immediate postpartum period. Am J Obstet Gynecol (2009) 1.54
17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol (2012) 1.49
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol (2009) 1.48
A randomized trial of amnioreduction versus septostomy in the treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol (2005) 1.48
A population-based case-control study of stillbirth: the relationship of significant life events to the racial disparity for African Americans. Am J Epidemiol (2013) 1.48
The fetal origins of hypertension: a systematic review and meta-analysis of the evidence from animal experiments of maternal undernutrition. J Hypertens (2012) 1.46
Contingent screening for Down syndrome--results from the FaSTER trial. Prenat Diagn (2008) 1.45
Comparison of serum markers in first-trimester down syndrome screening. Obstet Gynecol (2006) 1.43
Effect of gestational age and position on peak expiratory flow rate: a longitudinal study. Obstet Gynecol (2005) 1.42
Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol (2008) 1.41
A suggested approach for implementing CONSORT guidelines specific to obstetric research. Obstet Gynecol (2013) 1.38
Stillbirth Collaborative Research Network: design, methods and recruitment experience. Paediatr Perinat Epidemiol (2011) 1.31
Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet Gynecol (2010) 1.26
Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women. Obstet Gynecol (2012) 1.20
Putting the "M" back in maternal-fetal medicine. Am J Obstet Gynecol (2012) 1.14
Late preterm birth: how often is it avoidable? Am J Obstet Gynecol (2009) 1.11
Comparing uterine electromyography activity of antepartum patients versus term labor patients. Am J Obstet Gynecol (2005) 1.10
Maternal mortality, near misses, and severe morbidity: lowering rates through designated levels of maternity care. Obstet Gynecol (2012) 1.07
Labor-associated gene expression in the human uterine fundus, lower segment, and cervix. PLoS Med (2006) 1.06
A new system for determining the causes of stillbirth. Obstet Gynecol (2010) 1.06
Characterization of abdominally acquired uterine electrical signals in humans, using a non-linear analytic method. Med Biol Eng Comput (2006) 1.06
Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia. Am J Obstet Gynecol (2011) 1.00
Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. Obstet Gynecol (2011) 0.99
Association of zoonotic Ljungan virus with intrauterine fetal deaths. Birth Defects Res A Clin Mol Teratol (2007) 0.98
Sonographic myometrial thickness predicts the latency interval of women with preterm premature rupture of the membranes and oligohydramnios. Am J Obstet Gynecol (2005) 0.98
The effect of acculturation on progesterone/estriol ratios and preterm birth in Hispanics. Obstet Gynecol (2008) 0.97
Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol (2008) 0.97
Characterization of a murine model of fetal programming of atherosclerosis. Am J Obstet Gynecol (2007) 0.95
An algorithm for the estimation of gestational age at the time of fetal death. Paediatr Perinat Epidemiol (2013) 0.94
Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix. J Histochem Cytochem (2006) 0.94
The effect of dystocia and previous cesarean uterine scar on the tensile properties of the lower uterine segment. Am J Obstet Gynecol (2006) 0.94
Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia. Reprod Sci (2013) 0.93
Association between stillbirth and illicit drug use and smoking during pregnancy. Obstet Gynecol (2014) 0.93
Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol (2007) 0.93
Fetal origins of adult vascular dysfunction in mice lacking endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol (2004) 0.93
Uterine electromyography characteristics for early diagnosis of mifepristone-induced preterm labor. Obstet Gynecol (2005) 0.92
A Core Outcome Set for Evaluation of Interventions to Prevent Preterm Birth. Obstet Gynecol (2016) 0.91
Induction of premature labor and delivery by allergic reaction and prevention by histamine H1 receptor antagonist. Am J Obstet Gynecol (2004) 0.91
Use and misuse of the term "elective" in obstetrics. Obstet Gynecol (2011) 0.90
Role of second-trimester genetic sonography after Down syndrome screening. Obstet Gynecol (2009) 0.90
Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. Am J Obstet Gynecol (2002) 0.89
Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia. Am J Physiol Heart Circ Physiol (2009) 0.89
Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia. Am J Obstet Gynecol (2005) 0.88
Degranulation of uterine mast cell modifies contractility of isolated myometrium from pregnant women. Am J Obstet Gynecol (2004) 0.87
First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol (2007) 0.86
Cervical light-induced fluorescence in humans decreases throughout gestation and before delivery: Preliminary observations. Am J Obstet Gynecol (2003) 0.85
Maternal hypercholesterolemia leads to activation of endogenous cholesterol synthesis in the offspring. Am J Obstet Gynecol (2008) 0.85
The association of stillbirth with depressive symptoms 6-36 months post-delivery. Paediatr Perinat Epidemiol (2015) 0.85
Pregnancy complicated by cyclic vomiting syndrome. Obstet Gynecol (2009) 0.84
The role of massive transfusion protocols in obstetrics. Am J Perinatol (2012) 0.84
IgE-independent mast cell activation augments contractility of nonpregnant and pregnant guinea pig myometrium. Int Arch Allergy Immunol (2008) 0.84
Amniotic fluid metabolomic analysis in spontaneous preterm birth. Reprod Sci (2014) 0.84
Impairment of fetal growth potential and neonatal encephalopathy. Am J Obstet Gynecol (2003) 0.84
Approximately one-third of medically indicated late preterm births are complicated by fetal growth restriction. Am J Obstet Gynecol (2011) 0.84
Light-induced fluorescence of the human cervix decreases after prostaglandin application for induction of labor at term. Eur J Obstet Gynecol Reprod Biol (2005) 0.83
Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? Am J Obstet Gynecol (2006) 0.83
Transcranial doppler measurement of cerebral velocity indices as a predictor of preeclampsia. Am J Obstet Gynecol (2002) 0.83
Expression of 8-oxoguanine glycosylase in human fetal membranes. Am J Reprod Immunol (2014) 0.83
A genome-wide association study of early spontaneous preterm delivery. Genet Epidemiol (2015) 0.83
The first cesarean: role of "fetal distress" diagnosis. Semin Perinatol (2012) 0.82
The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate. Am J Obstet Gynecol (2002) 0.82
Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers. Am J Obstet Gynecol (2008) 0.82
Transgenerational effect of fetal programming on vascular phenotype and reactivity in endothelial nitric oxide synthase knockout mouse model. Am J Obstet Gynecol (2008) 0.81
Screening of lysyl oxidase (LOX) and lysyl oxidase like (LOXL) enzyme expression and activity in preterm prelabor rupture of fetal membranes. J Perinat Med (2016) 0.81
Use of uterine EMG and cervical LIF in monitoring pregnant patients. BJOG (2005) 0.81
Can statins reduce the inflammatory response associated with preterm birth in an animal model? Am J Obstet Gynecol (2012) 0.81
Effects of recombinant human relaxin on pregnant rat uterine artery and myometrium in vitro. Am J Obstet Gynecol (2003) 0.81
Effect of intrauterine fetal programming on response to postnatal shaker stress in endothelial nitric oxide knockout mouse model. Am J Obstet Gynecol (2009) 0.81
The expression of antioxidant enzymes in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol (2012) 0.81
Endogenous mast cell degranulation modulates cervical contractility in the guinea pig. Am J Obstet Gynecol (2002) 0.81
The validity of cervical dilation as an indication of true labor between 32 and 36 weeks 6 days of gestation. Am J Obstet Gynecol (2007) 0.81
Does information available at delivery improve the accuracy of predicting vaginal birth after cesarean? Validation of the published models in an independent patient cohort. Am J Perinatol (2011) 0.80
Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol (2011) 0.80
Pharmacokinetics and pharmacotherapy of thionamides in pregnancy. Ther Drug Monit (2006) 0.80
L-arginine supplementation in patients with gestational hypertension: a pilot study. Hypertens Pregnancy (2007) 0.80
Fetal programming: Early-life modulations that affect adult outcomes. Curr Allergy Asthma Rep (2010) 0.80
Multivariate adaptive regression splines analysis to predict biomarkers of spontaneous preterm birth. Acta Obstet Gynecol Scand (2014) 0.80
Long-term alterations in maternal plasma proteome after sFlt1-induced preeclampsia in mice. Am J Obstet Gynecol (2013) 0.80
Effect of age and gender on the progression of adult vascular dysfunction in a mouse model of fetal programming lacking endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol (2011) 0.80
Burns in pregnancy. Obstet Gynecol (2005) 0.80
von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment. Am J Obstet Gynecol (2010) 0.79
Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: a secondary analysis of the DEEP Trial. Am J Obstet Gynecol (2013) 0.79
The effect of prepregnancy obesity and sFlt-1-induced preeclampsia-like syndrome on fetal programming of adult vascular function in a mouse model. Am J Obstet Gynecol (2009) 0.79
Acute myocardial infarction during pregnancy. Clin Obstet Gynecol (2014) 0.79
Platelet-activating factor antagonist WEB-2170 inhibits lipopolysaccharide-induced, but not antiprogestin-induced, preterm cervical ripening in timed-pregnant rats. Am J Obstet Gynecol (2003) 0.79
The role of oxidative stress in the developmental origin of adult hypertension. Am J Obstet Gynecol (2011) 0.79